Merck has overcome this potential for cancer.
—
Oh really? How?
I read it yesterday. I will look for it for you. No time now. The Mrs wants some honey-do’s.
Here is this link that tells how they aren’t concerned with mutations in humans. There is this comment:
” Merck has conducted a comprehensive nonclinical program to characterize the safety profile of molnupiravir. This program included assays such as Big Blue and PIG-a designed to provide a robust measure of a drug or chemical’s ability to induce mutations in vivo. Animals were administered molnupiravir for longer and at higher doses (mg/Kg) than those employed in human studies. The totality of the data from these studies indicates that molnupiravir is not mutagenic or genotoxic in in vivo mammalian systems.”
You can read the entire article: